ABEL: Type I Error [RSABE / ABEL]

posted by Helmut Homepage – Vienna, Austria, 2020-09-28 17:12 (112 d 05:22 ago) – Posting: # 21947
Views: 521

Dear all,

we know for a good while that under certain conditions the type I error might be inflated. However, seemingly European assessors were either not aware of it or ignored it. Last week I saw a deficiency letter (don’t ask for the country):

… in case of a value of 30% < CVRR <45%, it is recommended to check the control of the patient's risk type I error at the level of 5%. If an alpha adjustment is necessary, it is recommended that a BE estimate for the new CI of the T/R ratio be submitted to meet the extended bounds.

Kudos! Almost correct. The area of inflated TIEs may reach below 30% and only rarely (say, for a full replicate in 24 subjects) to 45%.

Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
21,303 posts in 4,441 threads, 1,487 registered users;
online 3 (0 registered, 3 guests [including 2 identified bots]).
Forum time: Monday 21:35 CET (Europe/Vienna)

I believe there is no philosophical high-road in science,
with epistemological signposts. No, we are in a jungle
and find our way by trial and error,
building our road behind us as we proceed.    Max Born

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5